Improving Liver Transplant Outcomes for Hepatitis C Virus Hepatocellular Carcinoma in the Direct-Acting Antiviral Therapy Era-Reference-Cited by-同舟云学术

Improving Liver Transplant Outcomes for Hepatitis C Virus Hepatocellular Carcinoma in the Direct-Acting Antiviral Therapy Era

Published:2022-09 Issue:7 Volume:54 Page:1834-1838
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Okumura Kenji^ORCID,Sogawa Hiroshi,Samson David,Butler Jonathan^ORCID,Veillette Gregory,John Devon^ORCID,Diflo Thomas,Bodin Roxana,Wolf David C.^ORCID,Latifi Rifat,Nishida Seigo

Funder

United Network for Organ Sharing

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference35 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades;Puigvehí;Am J Transplant,2020

3. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report;Clavien;Lancet Oncol,2012

4. Recurrent hepatocellular carcinoma after liver transplant: identifying the high-risk patient;Nissen;HPB (Oxford),2011

5. Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge;Welker;Transpl Int,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indications and outcomes of liver transplantation for liver tumors in the United States;Surgery in Practice and Science;2024-06

2. Design and Evaluation of an Educational Mobile Program for Liver Transplant Patients (Preprint);2022-09-27